Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: A multicenter study

Acta Urologica Japonica

Volumn 51, Issue 10, 2005, Pages 651-658

  Uchida, Toyoaki ^a   Baba, Shiro ^b   Irie, Akira ^b   Soh, Shigehiro ^b   Masumori, Naoya ^c   Tsukamoto, Taiji ^c   Nakatsu, Hiroomi ^d   Fujimoto, Hiroyuki ^e   Kakizoe, Tadao ^e   Ueda, Takeshi ^f   Ichikawa, Tomohiko ^f   Ohta, Nobutaka ^g   Kitamura, Tadaichi ^g   Sumitomo, Makoto ^h   Hayakawa, Masamichi ^h   Aoyagi, Teiichiro ⁱ   Tachibana, Masaaki ⁱ   Ikeda, Ryusuke ^j   Suzuki, Kohji ^j   Tsuru, Nobuo ^k   Suzuki, Kazuo ^k   Ozono, Seiichiro ^k   Fujimoto, Kiyohide ^l   Hirao, Yoshihiko ^l   Monden, Kohichi ^m   Nasu, Yasutomo ^m   Kumon, Hiromi ^m   Nishi, Kazuhiko ⁿ   Ueda, Shoichi ⁿ   Koga, Hirofumi ^o   Naitoh, Seiji ^o   more..

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

^d ASAHI GENERAL HOSPITAL   (Japan)

^e National Cancer Center

^f CHIBA UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

ⁱ TOKYO MEDICAL UNIVERSITY   (Japan)

^j KANAZAWA MEDICAL UNIVERSITY   (Japan)

^k HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l NARA MEDICAL UNIVERSITY   (Japan)

^m OKAYAMA UNIVERSITY   (Japan)

ⁿ KUMAMOTO UNIVERSITY   (Japan)

^o KYUSHU UNIVERSITY   (Japan)

more..

Author keywords

High intensity focused ultrasound; Minimally invasive surgery; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; EPIDIDYMITIS; ERECTILE DYSFUNCTION; FECES INCONTINENCE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY; NEPHROTIC SYNDROME; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; QUALITY OF LIFE; RETROGRADE EJACULATION; SYMPTOMATOLOGY; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; ULTRASOUND; URETHRA STRICTURE; URINE FLOW RATE; URINE INCONTINENCE;

ADULT; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 28244454219     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Landis SH, Murray T, Bolden S, et al.: Cancer statistics, 1999. CA Cancer J Clin 49: 8, 1999
2. Hull GW, Rabbani F, Abbas F, et al.: Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167: 528-534, 2002
3. Roehl KA, Han M, Ramos CG, et al.: Cancer progression and survival rate following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 172: 910-914, 2004
4. Zelefsky MJ, Hollister T, Raben A, et al.: Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phy 47: 1261-1266, 2000
5. Guillonneau B, el-Fettouh H, Baumert H, et al.: Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris experience. J Urol 169: 1261-1266, 2003
6. Han K-R, Cohen JK, Miller RJ, et al.: Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 170: 1126-1130, 2003
7. Lerner SE, Blute ML and Zinke H: Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol 154: 1103-1109, 1995
8. Madersbacher S, Pedevilla M, Vingers L, et al.: Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55: 3346-3351, 1995
9. Uchida T, Sanghvi NT, Gardner TA, et al.: Transrectal high-intensity focused ultrasound for treatment of patients with stageTlb-2N0M0 localized prostate cancer : a preliminary report. Urology 59: 394-399, 2000
10. Uchida T, Tsumura H, Yamashita H, et al.: Transrectal high-intensity focused ultrasound for treatment of patients with stageTlb-2N0M0 localized prostate cancer: a preliminary report. Jpn J Endourol ESWL 16: 108-114, 2003
11. Sobin LH and Wittekind CH: TNM classification of Malignant Tumors (5th ed). Wiley-Liss Inc, 1997
12. Cella DF, Tulsky DS, Gray G, et al.: The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11: 570-579, 1993
13. Japanese Urological Association and the Japanese Society of Pathology. General Rule for Clinical and Pathological Studies on Prostate Cancer. April 2001 (The 3rd edition). Tokyo, Kanehara Co
14. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37: 1035-1041, 1997
15. National Cancer Institute-Common Toxicity Criteria. Version 2.0, April 30, 1999
16. Gelet A, Chaperon JY, Bouvier R, et al.: Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 29: 174-183, 1996
17. Beerlage HP, Thüroff S, Debruyne FMJ, et al.: Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 54: 273-277, 1999
18. Gelet A, Chapelon JY, Bouvier R, et al. : Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer : factors influencing the outcome. Eur Urol 40: 124-129, 2001
19. Chaussy CG and Thüroff S: The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 4: 248-252, 2003
20. Thüroff S, Chaussy C, Vallancien G, et al.: High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17: 673-677, 2003
21. Vallancien G, Prapotnich D, Cathelineau Y, et al.: Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 171: 2265-2267, 2004
22. D'Amico AV, Schultz D, Schneider L, et al.: Comparing prostate specific antigen outcome after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors. J Urol 163: 1797-1801, 2000
23. Kupelian PA, Potters L, Khuntia D, et al.: Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72Gy, permanent seed implantation, or combines seed/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Biol Phys 58: 25-33, 2004
24. Gelet A, Chapelon JY, Poissonnier L, et al.: Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63: 625-629, 2004